Leukocytes produce many biological mediators that orchestrate the subs
equent cellular events during wound healing, We have identified a nove
l cytokine, leukocyte-derived growth factor (LDGF), which is mitogenic
for connective tissue cells, Sequence analysis of the LDGF peptide re
vealed that it is a precursor of other known peptides including platel
et basic protein (PBP), connective tissue activating peptide III (CTAP
-III), and neutrophil activating peptide 2 (NAP-2). None of these shor
ter peptides are active as mitogens for fibroblasts, LDGF appears to s
timulate fibroblast growth by stimulation of tyrosine kinase activity
of the PDGF receptors. One of the truncated products of LDGF, NAP-S, i
s a potent neutrophil chemoattractant, Peptides larger than NAP-2, suc
h as PBP and CTAP-III, are not active as neutrophil chemoattractants,
Collectively, these findings demonstrate that the LDGF peptide must re
main intact in order to retain its fibroblast mitogenic activity, If t
he LDGF peptide is processed to release the carboxyl terminal half to
generate NAP-S, a peptide with proinflammatory activity is generated,
These results indicate that the multiple peptides produced from the LD
GF-PBP gene posses divergent biological activities that could regulate
different phases of the repair process.